BCM
OFIX icon

BlueCrest Capital Management’s Orthofix Medical OFIX Stock Holding History

BlueCrest Capital Management’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-9,027
Closed -$531K – 1720
2018
Q1 		$531K Buy
+9,027
New +$506K 0.02% 740

Other funds holding OFIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

BlueCrest Capital Management's OFIX Position: Q2 2018 in Review

BlueCrest Capital Management sold out of Orthofix Medical (OFIX) in Q2 2018, closing a stake of 9,027 shares — an estimated $531K sold.

BlueCrest Capital Management first reported a position in OFIX in Q1 2018 and held it in 1 quarter. The position peaked at $531K in Q1 2018. 163 funds tracked by Wall St. Rank hold OFIX as of Q2 2018.

  • BlueCrest Capital Management reported no remaining Orthofix Medical position as of Q2 2018 after selling out during the quarter.
  • BlueCrest Capital Management sold 9,027 Orthofix Medical shares in Q2 2018, an estimated $531K.
  • BlueCrest Capital Management first reported a position in Orthofix Medical in Q1 2018 and held it in 1 quarter.
  • BlueCrest Capital Management's Orthofix Medical position peaked at $531K in Q1 2018.
  • 163 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2018.

Based on BlueCrest Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.